DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
Clinical trial
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
NCT00363519
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Sitagliptin phosphate
Normalized identity: sitagliptin phosphateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedControlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
PlaceboDRUG
Sitagliptin phosphateDRUG · verified · RxNorm: sitagliptin phosphate
Sponsors & collaborators
Ono Pharmaceutical Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00363519 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.